Mifepristone is facing greater scrutiny: Here’s why that is a good thing
By Easton Martin | December 10, 2025
Texas and Florida have filed a federal lawsuit challenging the approval of Mifepristone, the aptly named “abortion pill”. The lawsuit argues that the U.S. Food and Drug Administration did not properly evaluate the drug’s safety and effectiveness. The states also challenge rules allowing telehealth prescriptions and mail delivery, which make the drug widely available despite its lethal purpose.
Mifepristone works by blocking the hormone progesterone, which is essential for sustaining a pregnancy. Without it, the unborn child dies and the pregnancy is terminated. This is not a potential life or a cluster of cells; it is the intentional ending of a unique human being.
In addition to killing a child, the drug carries serious health risks for the mother. Large studies and insurance claims analyses show that some women experience heavy bleeding, infection, incomplete abortion requiring surgery, and in rare cases, death. Critics argue that the true risk of complications is higher than official estimates suggest, raising questions about the drug’s safety and the FDA’s oversight.
The lawsuits in Texas and Florida are drawing attention to both the moral and medical concerns surrounding Mifepristone. By challenging its approval and restricting its distribution, these states are seeking to protect unborn children and prevent the avoidable harm caused by this dangerous medication.
